Guggenheim Maintains Buy on Incyte, Raises Price Target to $150

Benzinga Newsdesk www.benzinga.com Positive 71.9%

Neg 0% Neu 0% Pos 71.9%

Guggenheim maintains Incyte (NASDAQ:INCY) with a Buy and raises the price target from $136 to $150.

Comments

No comments yet. Be the first!